Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CCM vs RDNT vs USPH vs AMSF

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCM
Concord Medical Services Holdings Limited

Medical - Care Facilities

HealthcareNYSE • CN
Market Cap$748K
5Y Perf.-63.0%
RDNT
RadNet, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$4.45B
5Y Perf.+237.4%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%
AMSF
AMERISAFE, Inc.

Insurance - Specialty

Financial ServicesNASDAQ • US
Market Cap$569M
5Y Perf.-50.6%

CCM vs RDNT vs USPH vs AMSF — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCM logoCCM
RDNT logoRDNT
USPH logoUSPH
AMSF logoAMSF
IndustryMedical - Care FacilitiesMedical - Diagnostics & ResearchMedical - Care FacilitiesInsurance - Specialty
Market Cap$748K$4.45B$897M$569M
Revenue (TTM)$366M$2.04B$695M$325M
Net Income (TTM)$-163M$47M$11M$46M
Gross Margin-11.4%11.2%22.0%47.6%
Operating Margin-131.0%3.0%12.2%17.8%
Forward P/E1.2x91.8x20.6x14.4x
Total Debt$3.93B$1.86B$426M$491K
Cash & Equiv.$216M$767M$36M$62M

CCM vs RDNT vs USPH vs AMSFLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCM
RDNT
USPH
AMSF
StockMay 20May 26Return
Concord Medical Ser… (CCM)10037.0-63.0%
RadNet, Inc. (RDNT)100337.4+237.4%
U.S. Physical Thera… (USPH)10079.6-20.4%
AMERISAFE, Inc. (AMSF)10049.4-50.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCM vs RDNT vs USPH vs AMSF

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AMSF leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. U.S. Physical Therapy, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. CCM and RDNT also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CCM
Concord Medical Services Holdings Limited
The Value Play

CCM is the clearest fit if your priority is value.

  • Lower P/E (1.2x vs 14.4x)
Best for: value
RDNT
RadNet, Inc.
The Long-Run Compounder

RDNT is the clearest fit if your priority is long-term compounding.

  • 9.5% 10Y total return vs AMSF's 31.8%
  • +4.6% vs AMSF's -29.2%
Best for: long-term compounding
USPH
U.S. Physical Therapy, Inc.
The Growth Play

USPH is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • 16.3% revenue growth vs CCM's -28.6%
  • 3.1% yield, 5-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend)
Best for: growth exposure
AMSF
AMERISAFE, Inc.
The Insurance Pick

AMSF carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.23, yield 8.4%
  • Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
  • Beta 0.23, yield 8.4%, current ratio 0.32x
  • 14.3% margin vs CCM's -44.6%
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs CCM's -28.6%
ValueCCM logoCCMLower P/E (1.2x vs 14.4x)
Quality / MarginsAMSF logoAMSF14.3% margin vs CCM's -44.6%
Stability / SafetyAMSF logoAMSFBeta 0.23 vs RDNT's 1.43, lower leverage
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend)
Momentum (1Y)RDNT logoRDNT+4.6% vs AMSF's -29.2%
Efficiency (ROA)AMSF logoAMSF5.6% ROA vs CCM's -2.4%, ROIC 21.9% vs -7.7%

CCM vs RDNT vs USPH vs AMSF — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCMConcord Medical Services Holdings Limited
FY 2024
Services and other revenues
80.1%$372M
Medicine income
17.9%$83M
Equipment Leasing Revenues
2.0%$9M
RDNTRadNet, Inc.
FY 2025
Commercial Insurance1
58.8%$1.1B
Medicare1
24.8%$477M
Capitation Arrangements
6.5%$126M
Health Care, Other
3.4%$65M
Medicaid1
2.7%$52M
Workers' Compensation/Personal Injury1
2.3%$45M
Health Care, Management Service
1.4%$28M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
AMSFAMERISAFE, Inc.

Segment breakdown not available.

CCM vs RDNT vs USPH vs AMSF — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAMSFLAGGINGUSPH

Income & Cash Flow (Last 12 Months)

AMSF leads this category, winning 3 of 6 comparable metrics.

RDNT is the larger business by revenue, generating $2.0B annually — 6.3x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to CCM's -44.6%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.USPH logoUSPHU.S. Physical The…AMSF logoAMSFAMERISAFE, Inc.
RevenueTrailing 12 months$366M$2.0B$695M$325M
EBITDAEarnings before interest/tax-$359M$214M$107M$58M
Net IncomeAfter-tax profit-$163M$47M$11M$46M
Free Cash FlowCash after capex$0-$178M$67M$8M
Gross MarginGross profit ÷ Revenue-11.4%+11.2%+22.0%+47.6%
Operating MarginEBIT ÷ Revenue-131.0%+3.0%+12.2%+17.8%
Net MarginNet income ÷ Revenue-44.6%+2.3%+1.5%+14.3%
FCF MarginFCF ÷ Revenue-2.1%-8.7%+9.6%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year-8.3%+14.8%+7.7%+10.3%
EPS Growth (YoY)Latest quarter vs prior year+84.0%-114.1%-115.0%-8.5%
AMSF leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

CCM leads this category, winning 3 of 6 comparable metrics.

At 12.3x trailing earnings, AMSF trades at a 70% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than RDNT's 25.9x.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.USPH logoUSPHU.S. Physical The…AMSF logoAMSFAMERISAFE, Inc.
Market CapShares × price$748,461$4.5B$897M$569M
Enterprise ValueMkt cap + debt − cash$547M$5.5B$1.3B$508M
Trailing P/EPrice ÷ TTM EPS-0.02x-230.00x41.55x12.27x
Forward P/EPrice ÷ next-FY EPS est.1.23x91.75x20.63x14.42x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple25.88x12.52x8.53x
Price / SalesMarket cap ÷ Revenue0.01x2.18x1.15x1.80x
Price / BookPrice ÷ Book value/share0.00x3.19x1.16x2.30x
Price / FCFMarket cap ÷ FCF52.01x14.71x63.83x
CCM leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

AMSF leads this category, winning 8 of 9 comparable metrics.

AMSF delivers a 9.7% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-10 for CCM. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), AMSF scores 7/9 vs CCM's 3/9, reflecting strong financial health.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.USPH logoUSPHU.S. Physical The…AMSF logoAMSFAMERISAFE, Inc.
ROE (TTM)Return on equity-9.8%+3.8%+1.4%+9.7%
ROA (TTM)Return on assets-2.4%+1.3%+0.9%+5.6%
ROICReturn on invested capital-7.7%+2.0%+5.6%+21.9%
ROCEReturn on capital employed-12.2%+2.1%+7.6%+16.8%
Piotroski ScoreFundamental quality 0–93557
Debt / EquityFinancial leverage2.43x1.37x0.55x0.00x
Net DebtTotal debt minus cash$3.7B$1.1B$390M-$61M
Cash & Equiv.Liquid assets$216M$767M$36M$62M
Total DebtShort + long-term debt$3.9B$1.9B$426M$491,000
Interest CoverageEBIT ÷ Interest expense-2.40x1.46x15.42x
AMSF leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

RDNT leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in RDNT five years ago would be worth $24,710 today (with dividends reinvested), compared to $1,512 for CCM. Over the past 12 months, RDNT leads with a +4.6% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors RDNT at 26.0% vs CCM's -27.2% — a key indicator of consistent wealth creation.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.USPH logoUSPHU.S. Physical The…AMSF logoAMSFAMERISAFE, Inc.
YTD ReturnYear-to-date+20.4%-19.0%-24.6%-18.3%
1-Year ReturnPast 12 months-28.4%+4.6%-14.3%-29.2%
3-Year ReturnCumulative with dividends-61.4%+100.0%-43.7%-24.8%
5-Year ReturnCumulative with dividends-84.9%+147.1%-43.4%-18.9%
10-Year ReturnCumulative with dividends-88.8%+947.4%+22.6%+31.8%
CAGR (3Y)Annualised 3-year return-27.2%+26.0%-17.4%-9.1%
RDNT leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — RDNT and AMSF each lead in 1 of 2 comparable metrics.

AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than RDNT's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RDNT currently trades 67.0% from its 52-week high vs CCM's 47.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.USPH logoUSPHU.S. Physical The…AMSF logoAMSFAMERISAFE, Inc.
Beta (5Y)Sensitivity to S&P 5000.53x1.43x0.93x0.23x
52-Week HighHighest price in past year$10.77$85.84$93.50$48.54
52-Week LowLowest price in past year$3.18$50.76$58.55$29.42
% of 52W HighCurrent price vs 52-week peak+47.7%+67.0%+63.1%+62.4%
RSI (14)Momentum oscillator 0–10067.551.346.134.2
Avg Volume (50D)Average daily shares traded11K822K171K212K
Evenly matched — RDNT and AMSF each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — USPH and AMSF each lead in 1 of 2 comparable metrics.

Analyst consensus: CCM as "Buy", RDNT as "Buy", USPH as "Buy", AMSF as "Buy". Consensus price targets imply 72.9% upside for USPH (target: $102) vs 46.9% for AMSF (target: $45). For income investors, AMSF offers the higher dividend yield at 8.41% vs USPH's 3.06%.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.USPH logoUSPHU.S. Physical The…AMSF logoAMSFAMERISAFE, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$92.00$102.00$44.50
# AnalystsCovering analysts211126
Dividend YieldAnnual dividend ÷ price+3.1%+8.4%
Dividend StreakConsecutive years of raises0050
Dividend / ShareAnnual DPS$1.80$2.55
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.6%+2.1%
Evenly matched — USPH and AMSF each lead in 1 of 2 comparable metrics.
Key Takeaway

AMSF leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 2 tied.

Best OverallAMERISAFE, Inc. (AMSF)Leads 2 of 6 categories
Loading custom metrics...

CCM vs RDNT vs USPH vs AMSF: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CCM or RDNT or USPH or AMSF a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCM or RDNT or USPH or AMSF?

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CCM or RDNT or USPH or AMSF?

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus CCM's -88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCM or RDNT or USPH or AMSF?

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 517% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — CCM or RDNT or USPH or AMSF?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Concord Medical Services Holdings Limited grew EPS -3. 6% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CCM or RDNT or USPH or AMSF?

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus -138. 6% for CCM. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CCM or RDNT or USPH or AMSF more undervalued right now?

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.

2x forward P/E versus 91. 8x for RadNet, Inc. — 90. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — CCM or RDNT or USPH or AMSF?

In this comparison, AMSF (8.

4% yield), USPH (3. 1% yield) pay a dividend. CCM, RDNT do not pay a meaningful dividend and should not be held primarily for income.

09

Is CCM or RDNT or USPH or AMSF better for a retirement portfolio?

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CCM and RDNT and USPH and AMSF?

These companies operate in different sectors (CCM (Healthcare) and RDNT (Healthcare) and USPH (Healthcare) and AMSF (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CCM is a small-cap quality compounder stock; RDNT is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; AMSF is a small-cap deep-value stock. USPH, AMSF pay a dividend while CCM, RDNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CCM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

RDNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

AMSF

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCM and RDNT and USPH and AMSF on the metrics below

Revenue Growth>
%
(CCM: -8.3% · RDNT: 14.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.